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Our challenges: getting insights from data
High throughput 
technologies drive modern 
biology.
Huge amount of biological 
data have been generated.
The bottleneck to achieve this goal is no longer a lack of 
data, but the lack of ingenuity and computational means to 
integrate knowledge and high-throughput data.
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Roles of computational biology
• Data are more comprehensive and unbiased, however, ‘real 
signals’ are buried in flood of data.
• By integrating these data, we could ask inspiring and 
fundamental questions (bio), develop elegantly computational 
methods (compute/stat/math) and lead to new insights (bio) 
into old data.
• More importantly, we could ask questions from a unique angle 
– considering biology and computation in an integrative 
manner.
• Insightful results in turn lead to ask new questions and design 
wet-lab experiments. 
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Cancer gene mutation, tremendous complex?
• Genome-wide sequencing of tumor genomes have revealed 
tremendous diversity and little overlap of causally mutated 
genes between individual patients' tumors, even for tumors of 
the same tissue origin.
Is that hopelessly complex?
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Tumor genome sequencing, useless?
It is time- and resource- consuming 
with unclear results?Na
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Cancer and cellular signaling 
• Cells use sophisticated communication between proteins in 
order to initiate and maintain basic cellular functions such as 
growth, survival, proliferation and development. 
• Alterations of cellular signaling events, such as those that arise 
by mutation or methylation, can result in tumor development.
• Cancer driver mutation: the mutated genes drive the rampant 
cell growth that causes cancer
– Oncogene: prompting the onset and development of cancer.
– Tumor suppressor gene: protecting a cell from one step on the path to 
cancer.
– DNA methylation: a type of chemical modification of DNA that leads 
to gene silencing.
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Questions on signaling and cancer
• Enormous efforts have been made over the past few 
decades to illustrate cancer signaling. However, it has 
been a struggle to get clues:
– How cancer signaling is structurally and functionally 
organized?
– Where the oncogenic stimuli are embedded in the network 
architecture? 
– Is any driving signaling event, ‘oncogenic signaling 
addiction’ (the signaling event is frequently used by cancer 
cells)?
– What are the principles of triggering oncogenic signaling 
events by genetic and epigenetic alterations?
– Are there any signaling partnerships generally used to 
generate tumor phenotypes?
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Oncogenic signaling, gene mutation and 
methylated gene silencing
Normal cellular signaling
Cancer signaling: red 
nodes represent cancer 
mutated or methylated 
genes. 
a b
0.2
0.2
0.1
0.1
Cancer signaling addiction:
the most frequently used 
signaling events and cascades 
by cancer cells. Numbers 
represent mutation 
frequencies.
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Datasets
• Analyzing the human signaling network by integrating 
‘cancer driver mutating’ and cancer stem cell methylated 
silencing genes.
• Manually curation of a human cellular network (>1,600 
proteins and >5,000 signaling relations), Cui et al., Mol Syst
Biol, 3:152, 2007.
• Cancer stem cell methylated silencing genes (93 genes 
mapped onto the network), Widschwendter et al., Nat Genet 39: 
157, 2007; Schlesinger  et al., Nat Genet 39: 232, 2007; Ohm et al., Nat 
Genet 39:237; 2007. 
• Cancer driver mutating genes (227 genes mapped onto the 
network), COSMIC database, literature curation and genome 
sequncing of tumors, Thomas et al., Nat Genet 39: 347, 2007;
Sjoblom et al., Science 314: 268, 2006.
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Human cellular signaling network
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Tumor genome sequencing vs literature 
curation
Driver mutating genes on the network, most of them 
have been determined from genome sequencing.
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Questions addressed
• Where are the oncogenic 
stimuli (cancer mutating and 
methylated-silencing genes) 
embedded and distributed in 
the network architecture?
• What are the principles by 
which genetic and 
epigenetic alterations trigger 
oncogenic signaling events? Na
t
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Output layer of the signaling network
• The downstream 
layer of the network 
is enriched with: 
- cancer driving 
mutating genes.
- highly mutated genes.
- microRNA-regulated 
genes.
• No such patterns for 
methylated-
silencing genes.  
Cui et al., Mol Syst Biol 2: 46, 2006 
Cui et al., Mol Syst Biol 3: 152, 2007
Awan et al., IET Syst Biol 1: 292, 2007
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Mutating oncogenes and network motifs
• The more mutating nodes a 
motif has, the more positive 
links that motif has.
• Because the positive loops 
must constitutively activate 
downstream nodes, this 
pattern suggest that oncogene
mutation results in gain-of-
function of the mutants. 
• Experimentally validated 
examples: PI3K in tumors,
Gymnopoulos et al., PNAS, 104: 
5569, 2007.
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Methylated genes and network motifs
• The more methylated 
nodes a motif has, the 
less positive links that 
motif has.
• The mutated tumor 
suppressors share the 
same pattern.
• Gene silencing and 
tumor suppressor 
mutation could break 
the negative feedback 
loops. 
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Questions addressed
• Given that so many genes have genetic and epigenetic 
aberrations in cancer signaling,
– What is the architecture of cancer signaling?
– Do any tumor-driven signaling events represent 
‘oncogenic addiction’ (the phenomenon by which 
certain cancer cells become dependent on certain 
signaling cascades for growth or survival)? 
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Human cancer signaling map
Almost ~10% of the genes are highly mutated and most frequently 
used by cancer cells, furthermore, they form 3 network regions (cancer 
signaling superhighways).  
Uncovered 
well-known 
cancer 
signaling events
Suggested 
many putative 
cancer 
signaling events
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Questions addressed
• Given that so many genes have genetic and 
epigenetic aberrations in cancer signaling:
– Who are the central players in oncogenic 
signaling? 
– Are there any signaling partnerships generally used 
to generate tumor phenotypes? Na
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Network community
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Collaboration of network communities in 
tumorigenesis
a
b
c
d
NCI-60 
cell lines
Breast and 
colon tumor 
genome 
sequencing
Common module
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Representative cancer types
blood
CNSa b c
d e f
Blood Breast
Lung Pancreas Skin
1. Tumorigenesis: common module + tumor type specific modules.
2. Suggest that breast and lung cancers have more signaling mechanisms, therefore, 
more subtypes (true), easily occur than others (top cancer types in the world).
N
a
t
u
r
e
 
P
r
e
c
e
d
i
n
g
s
 
:
 
d
o
i
:
1
0
.
1
0
3
8
/
n
p
r
e
.
2
0
0
8
.
2
2
3
8
.
1
 
:
 
P
o
s
t
e
d
 
2
7
 
A
u
g
 
2
0
0
8
Challenge the current view of cancer signaling
• Signaling pathways and their collaborations driver 
cancer development and progression.
• However, almost all of the known signaling pathways 
can be charted by the “cancer driver mutating genes”. 
• We dissected a few key protein communication 
modules, and showed that clear patterns of signaling 
module collaborations emerge recurrently in tumor 
samples.
• It represents the underlying ‘logic’ of cancer 
signaling and a more accurate view of how cancers 
originate.
N
a
t
u
r
e
 
P
r
e
c
e
d
i
n
g
s
 
:
 
d
o
i
:
1
0
.
1
0
3
8
/
n
p
r
e
.
2
0
0
8
.
2
2
3
8
.
1
 
:
 
P
o
s
t
e
d
 
2
7
 
A
u
g
 
2
0
0
8
Summary
• Provided a framework for discovering preferred combinations 
of signaling cascades used by cancer cells.
• Uncovered the underlying logic of cancer signaling: a protein 
communication module is predominantly used to collaborate 
with other modules (different for different types of cancer) in 
tumorigenesis and progression.
• Provided a framework for network analysis of the high-
throughput genome sequencing of cancer and other disease 
samples. 
• Details of this work: Cui et al., A map of human cancer 
signaling, Mol Syst Biol, 3:152, 2007.
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